✓ Plata cu cardul restabilită — finalizare securizată prin Privacy Shield

Torvate

Torvate (Sodium valproate 200/300/500 mg) — anticonvulsant mood stabiliser for epilepsy, bipolar mania, migraine prophylaxis. contraindicated in pregnancy and women of childbearing potential.

Verificat medical de Morgan Ellis — Cercetător farmaceutic · 8 ani de experiență  · Ultima recenzie: mai 2026

Cumpără mai mult, economisește mai mult Preț pe tabletă
30 tablete
US$0.87/comprimat
US$26.00
60 Comprimat/e
US$0.73/tablet · save 15%
US$44.00
90 Tabletă/tablete
US$0,64/comprimat · save 26%
US$58,00
180 Tablete CEA MAI BUNĂ OFERTĂ
US$0,52/comprimat · save 40%
US$94,00
Plată criptată
Plățile în crypto reduc prețul cu 10%
Livrare discretă în întreaga lume
1.400+ clienți · 50+ țări

⚡ Quick Answer

Torvate (Sodium valproate 200 / 300 / 500 mg) is an anticonvulsant and mood stabiliser used for epilepsy, bipolar mania, and migraine prophylaxis. Absolute contraindication in pregnancy and women of childbearing potential without strict pregnancy-prevention measures — high teratogenicity and neurodevelopmental risk.

Ce beneficii oferă MedsBase: Producător certificat WHO-GMP · Ambalaj discret · Livrare la nivel mondial · Peste 1.400 de recenzii verificate ale clienților

📦 Fiecare comandă este acoperită de politica noastră de Politica noastră de Reexpediere Garantată — dacă coletul dumneavoastră nu sosește în 20 de zile lucrătoare, îl relivrăm.

De ce să comanzi de la MedsBase

Torvate at MedsBase is supplied directly from a WHO-GMP certified manufacturer in plain, discreet packaging. Every order is covered by our Politica noastră de Reexpediere Garantată — 20-business-day arrival window or we reship at no charge — and qualifies for our customer loyalty programme. Worldwide shipping is available to most destinations.

What Torvate is and how it works

Torvate is a sodium valproate tablet supplied by Torrent. Available strengths: 200 / 300 / 500 mg. Valproate is a broad-spectrum anticonvulsant whose anti-seizure mechanisms include sodium-channel blockade, T-type calcium-channel modulation, and increased GABA availability. The anti-manic mechanism is poorly understood but well-evidenced in trials.

Pregnancy — absolute contraindication outside epilepsy

Valproate is one of the most teratogenic medications in routine use. First-trimester exposure produces neural tube defects (~ 1–2% absolute risk), cardiac and skeletal malformations, and a substantial reduction in childhood IQ (mean 7–10 points lower at age 6). UK MHRA, EMA, and FDA all require strict pregnancy-prevention programmes for women of childbearing potential. Outside refractory epilepsy where no alternative exists, do not initiate or continue valproate in any woman of childbearing potential without effective contraception and a pregnancy-prevention programme. Switch to lithium, lamotrigine, or an atypical antipsychotic for bipolar maintenance in pre-menopausal women.

Indications and dosing

IndicationStartingTargetTarget level
Generalised epilepsy10–15 mg/kg/day in 2 doses20–60 mg/kg/day50–100 µg/mL
Bipolar mania (acute)20–30 mg/kg/day in 2 doses20–60 mg/kg/day50–125 µg/mL
Bipolar maintenance500–2500 mg/day50–100 µg/mL
Migraine prophylaxis250 mg BID500–1500 mg/day
Older adults / hepatic concernhalve dose

Important safety considerations

Hepatotoxicity

Idiosyncratic fatal hepatitis is a recognised valproate complication, highest risk in children < 2 years on polytherapy. Mandatory baseline LFTs and recheck at 3 months, 6 months, then yearly. Stop immediately for jaundice, hepatomegaly, RUQ pain, or unexplained AST/ALT > 3× ULN.

Pancreatitis (rare)

Acute haemorrhagic pancreatitis described, including paediatric fatal cases. Stop for unexplained abdominal pain, vomiting, anorexia.

Hyperammonaemia

Valproate inhibits the urea cycle; hyperammonaemia can occur even with normal LFTs and produces drowsiness, confusion, and (rarely) encephalopathy. Check ammonia in patients with new lethargy or cognitive change.

Polycystic ovary syndrome and metabolic effects

Long-term valproate is associated with weight gain, insulin resistance, and PCOS in young women — another reason to prefer alternatives in pre-menopausal women.

Thrombocytopenia and platelet dysfunction

Mild thrombocytopenia is common; check FBC at baseline, 3 months, 6 months. Significant thrombocytopenia is rare.

Common side effects

  • GI: nausea, abdominal pain, dyspepsia — universal at initiation; XR/EC formulations help.
  • Tremor — common at higher doses or levels.
  • Sedation — common.
  • Weight gain — typically 4–8 kg over 12 months.
  • Hair thinning / alopecia — common; biotin supplementation sometimes recommended.
  • Hyperammonaemia — silent or symptomatic.
  • Thrombocytopenia — usually mild.
  • Cognitive blunting — at higher doses.

Drug interactions

  • Lamotrigine — valproate inhibits lamotrigine glucuronidation; lamotrigine starting dose must be halved when added to valproate (Stevens-Johnson syndrome risk).
  • Carbamazepine, phenytoin, phenobarbital — bidirectional interactions; level changes likely.
  • Aspirin, warfarin — protein-binding displacement; level/free-fraction changes.
  • Carbapenem antibiotics — dramatically lower valproate levels; clinically significant.
  • Topiramate — additive hyperammonaemia risk.

Pregnancy, breastfeeding, paediatric

Pregnancy: high teratogenicity and neurodevelopmental risk; absolute contraindication outside refractory epilepsy with strict pregnancy-prevention programme. Breastfeeding: passes into milk in low amounts; usually compatible. Paediatric: licensed for epilepsy from infancy; particular hepatotoxicity risk in children < 2 on polytherapy.

Depozitare

Store at 15–30 °C in original packaging.

Întrebări frecvente

Why is valproate so restricted in women?

First-trimester valproate exposure produces neural tube defects, cardiac malformations, skeletal malformations, and a substantial reduction in childhood IQ (mean 7–10 points lower at age 6). The risks are among the highest of any drug in routine use. UK MHRA, EMA, and FDA all require strict pregnancy-prevention programmes for women of childbearing potential. In bipolar disorder, alternatives (lithium, lamotrigine, atypical antipsychotics) should be used in pre-menopausal women.

Why does valproate need blood-level monitoring?

Therapeutic levels for bipolar mania (50–125 µg/mL) and epilepsy (50–100 µg/mL) define the response window. Below the range, treatment fails; above it, side effects rise without proportional benefit. Trough levels (12 hours post-dose) at steady state guide dosing.

How long until valproate works?

Acute mania: response within 1–2 weeks of reaching therapeutic level. Maintenance: 4–6 weeks for full effect. Migraine prophylaxis: 4–8 weeks.

Will valproate make me gain weight?

Yes — typically 4–8 kg over 12 months. Less than olanzapine, more than lithium. Active weight management from initiation.

Can valproate cause liver damage?

Idiosyncratic fatal hepatitis is recognised, particularly in children < 2 years on polytherapy. In adults, the absolute risk is low but real. Mandatory LFT monitoring; stop for unexplained jaundice, RUQ pain, or AST/ALT > 3× ULN.

Why does valproate cause hair loss?

Valproate causes a telogen effluvium pattern in approximately 5–10% of users — diffuse thinning, sometimes substantial. Most regrows on dose reduction or after stopping. Some clinicians recommend zinc and biotin supplementation; evidence is thin but the supplements are low-risk.

Can I drink alcohol on valproate?

Heavy alcohol use is contraindicated because of additive hepatotoxicity. Light alcohol is usually tolerated; binge drinking is dangerous.

Can valproate be stopped abruptly?

In epilepsy, abrupt cessation can precipitate status epilepticus — taper over weeks. In bipolar disorder, abrupt cessation produces a meaningful spike in relapse risk; taper over 2–4 weeks.

Why does combining valproate with lamotrigine need a special protocol?

Valproate inhibits lamotrigine glucuronidation, raising lamotrigine levels 2-fold. Lamotrigine starting doses must be halved when added to valproate, and titration must be slow — fast titration with valproate raises Stevens-Johnson syndrome risk substantially.

What about driving on valproate?

Sedation can impair reaction time, particularly in the first 1–2 weeks and at higher levels. Most patients on stable doses drive normally.

Other Mental Health Medications

Notă medicală. This page is educational and is not a substitute for individualised medical advice. Mental-health pharmacotherapy should be initiated, monitored, and adjusted under a qualified clinician. If you or someone you know is in suicidal crisis, contact local emergency services immediately, or call your country’s suicide-prevention helpline (US/Canada: 988; UK: Samaritans 116 123; international list: findahelpline.com).

More options in Mental Health and Psychiatric Medications

Clasificate în funcție de volumul recent de comenzi MedsBase — ce aleg alți clienți în această categorie.

Concentrație

500 mg

Cantitate

30 Comprimat/e, 60 Comprimat/e, 90 Comprimat/e, 180 Comprimat/e

Recenzii

Nu există recenzii încă

Adăugați o recenzie
Torvate Torvate
Evaluare*
0/5
* Evaluarea este obligatorie
* Răspunsul este obligatoriu
Recenzia dvs.
* Recenzia este obligatorie
Nume
* Numele este obligatoriu
Adăugați fotografii sau videoclip la recenzia dvs.

Întrebări și răspunsuri

Pune o întrebare
Torvate Torvate
Întrebarea ta
* Întrebarea este obligatorie
Nume
* Numele este obligatoriu
Nu există întrebări încă